A series of sebacoyl N, N-bis(substituted-alkyl-2-thioureido)alkyl carboxylic acid or ester derivatives 3-12 bearing an amino acid ester residue were prepared by a one-pot sequential reaction of sebacoyl chloride 1 with NH 4 SCN and amino acid or their ester hydrochlorides. Analogously, the sebacoyl-phthalimido derivatives 16 and 17 were prepared from treatment of 1 with phthalimide precursors. Treatment of 5 and 7 with Br 2 in acetone furnished the iminothiazole analogues 18 and 19, respectively. Compounds 5, 6, 8-11 and 16 have been selected for their inhibitory activity screening against HIV-1 and HIV-2 in MT-4 cells.
Introduction
HIV-1 reverse transcriptase is a key enzyme in the HIV replication as well as a key target for developing anti-HIV drugs. Two types of reverse transcriptase inihibitors have been developed 1, 2 : nucleoside reverse transcriptase inihibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTI). Three NNRTIs, nevirapine, 3 delaviridine, 4 and efavirenz 5 have been approved by FDA for the treatment of HIV infection. However, significant resistance has been developed against the current NNRTI and there is an urgent need to develop new anti-HIV agents that are effective against these resistance mutants. 6, 7 We have reported recently the synthesis of new nitroimidazoles with remarkable anti-HIV activity [8] [9] [10] [11] [12] as NNRTIs candidates.
Several heterocyclic thioureas have been reported as a new class of potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as phenethylthiazolyl-thiourea (PETT) derivatives.
active amino acid coupled derivatives was considered to be of a major interest. [18] [19] [20] [21] Recently, Fathalla et al. 22, 23 reported new quinazoline thioureas derivatives bearing an amino acid ester residue based on domino reaction of N- (2-cyanophenyl) benzimidoyl isothioyanate with amino acid methyl ester hydrochlorides.
In continuation of our work on amino acid derivatives, [24] [25] [26] [27] we described here the development of a new series of thioureas bearing amino acids or their ester analogues which can be used as potent NNRTI's
Results and Discussion
In our present work, sebacoyl chloride (octane-1,8-dicarboxylic acid dichloride) 1 has been selected as a spacer building block 28 for the synthesis of new derivatives of sebacoyl-N,Nbis(substituted-alkyl-2-thioureido)alkyl carboxylic acid or ester aiming for evaluation of their anti-HIV activity. Koenig et al. 29 have used 1 for the synthesis of 3,3,3',3'-tetraethyl-1,1'-sebacoyl-bis(thiourea) and other analogues via the sebacoyl dithiocyanate derivative 2.
Compound 2 was the key intermediate for synthesis of the compounds investigated in our work. Thus, treatment of 1 with NH 4 SCN in acetone, following Kabbani approach, 30 afforded 2 which was directly treated with the desired amino acid derivatives to give, after purification, the sebacoyl-thioureido-amino acid derivatives in 63-86% yield. The synthetic reactions are summarized in scheme 1. The structures of 3-12 were determined by their 1 H, 13 C NMR and by mass spectra. The sebacoyl protons showed almost a similar pattern. H-7 and H-14 protons appeared as multiplets in the region δ 2.61-1.78 ppm, while H-8 and H-13 proton signals are oriented as multiplets in the region δ 1.81-1.45 ppm. H-9 -H-12 were appeared as multiplets in the region δ H-2 of the amino acid moieties are oriented in the region δ with different multiplicities, depending on the functional group adjacent to H-2. The other protons of the amino acids or esters were fully analyzed. The
13
C NMR spectra of 3-12 contained almost similar resonance signals of the sebacoyl C-7 -C-14 and thioureido carbon atoms. The chemical shifts between δ 188.8 and 184.25 ppm were assigned to C=S carbon atom of the thioureido moiety (C-4), while the resonances in the range of δ 177.7-174.1 ppm were assigned to the carbonyl groups of the CSNHCO residues. C-2 of the amino acid moieties [CH-CO 2 H(Me,Et)] appeared in the region δ 66.7-55.9 ppm. The sebacoyl carbon atoms C-7 and C-14 are oriented in the region δ 38.0-35.3, while C-8 and C-13 were appeared in the region δ 26.4-25.0 ppm. The signals between δ   31.5 and 24.7 ppm were attributed to C-9 and C-12.
The proton spin system of 11 was further identified from DFQ-COSY 31 Further, our work was modified by selecting 5 and 7 as precursors for the synthesis of new analogues of sebacoyl-2-imino-thiazole. Thus, treatment of 5 and 7 with acetone and bromine under reflux led to cyclization of the thioureido residue furnishing the 2-imino-thiazole derivatives 18 and 19 in 65 and 71% yields, respectively (Scheme 3). The structures of 18 and 19 were determined from their 1 H-, 13 C NMR and mass spectra. The sebacoyl protons showed rather similar pattern for the sebacoyl (CH 2 ) protons for those of 16 and 17. The singlets at δ 5.87 and 5.92 ppm were assigned to H-5 of the thiazole ring, respectively, while the singlets at δ 1.70 and 1.68 ppm were attributed to the methyl groups at C-4 of the thiazole moiety. In the 13 C NMR of 18 and 19, the resonances at δ 163.8 and 163.6 ppm, were attributed to C=N (C-2), respectively, whereas the signals at δ 132.9 and 132.7 ppm were assigned to C-4, respectively. C-5 were oriented between δ 100.1 and 99.8 ppm, respectively. The structures of 18 and 19 were further confirmed by the gradient 33 selected HMBC spectra. H-5 of the thiazole ring at δ H 5.87 and 5.92 ppm showed 2 J C,H couplings with C-4 of the thiazole ring at δ C 132.9 and 132.7 ppm, as well as 3 J C,H couplings with C=N (C-2) of the thiazole ring at δ C 163.8 and 163.6 ppm, respectively. 
In vitro anti-HIV assay
Compounds 5, 6, 8-11 and 16 were tested for their in vitro anti-HIV-1 (strain III B ) and HIV-2 (strain ROD) activity in human T-lymphocyte (MT-4) cells, based on MTT assay. 35 None of the new compounds were found to inhibit HIV-1 and HIV-2 replication, in vitro, at IC 50 lower than the CC 50 in comparison to the antiviral agents Nevirapine (BOE/BIRG587) 36 and azidothymidine (AZT). 37 In conclusion, the above data showed no selective anti-HIV activity.
Experimental section
General. Melting points are uncorrected and were measured on a Büchi melting point apparatus B-545 (Büchi Labortechnik AG, Switzerland). Microanalytical data were obtained with a Vario, Elemental apparatus (Shimadzu, Japan). NMR spectra were recorded on 400 and 600 MHz ( -N,N-bis(2-thioureido-3-(indol-3-yl) 
Sebacoyl-N,N-bis-ethyl-(6-amino-2-thioureido)hexanoate (6)
.
Sebacoyl-N,N-bis(2-thioureido-3-(imidazol-4-yl))propanoic acid (9).

Sebacoyl-N,N-bis-phthalimide (16).
A solution of sebacoyl chloride 1 (2.39 g, 10.0 mmol) and phthalimide 13 (2.94 g, 20 mmol) ) in acetone (25 mL) was heated under reflux for 5 h. After cooling the solution was evaporated to dryness to give a crude product followed by washing with water and EtOH. 
Sebacoyl-N,N-bis-methyl-(3-methyl-2-imino-thiazol-3-yl)butanoate (18).
To a stirred solution of 5 (0.55 g, 1.0 mmol) in dry acetone (20 mL) was added Et 3 N (1.0 mmol), followed by a dropwise addition of a bromine solution (1.0 mmol) in acetone (10 mL). The reaction mixture was stirred at room temperature for 2 h, then the mixture was evaporated to dryness to give the desired product, which were recrystallized from EtOH to afford 18 (0.41 g, 65%), mp 252-254 o C. 1 
